0.0870SEK-18.69%Mkt Cap: 117.43M SEKP/E: —Last update: 2026-05-21
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae …
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap117.43M SEK
Enterprise Value62.50M SEK
Revenue (TTM)2.65M SEK
Gross Profit1.76M SEK
Net Income (TTM)-26.81M SEK
Revenue/Share0.0030 SEK
Last Price0.0870 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountrySE
SectorHealth Care
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.49
EV/Revenue23.62
P/S44.38
P/B-87.00
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.040221% of range0.2610
52W High0.2610 SEK
52W Low0.0402 SEK
Profitability
Gross Margin109.29%
Oper. Margin-472.77%
EBITDA Margin0.00%
Profit Margin-1660.12%
ROE5704.47%
ROA-18.07%
Growth
Revenue Growth648.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.05M SEK
CapEx (TTM)224.00K SEK
FCF Margin-510.81%
FCF Yield-11.51%
Net Debt-10.76M SEK
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity-5.44
Current Ratio0.99
Quick Ratio0.90
Book Value/Sh-0.0010 SEK
Cash/Share0.0130 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.35B
Float760.49M
Insiders7.24%
Institutions0.44%
Technical
SMA 500.0928 (-6.2%)
SMA 2000.0997 (-12.8%)
Beta—
S&P 52W Chg27.23%
Avg Vol (30d)218.11K
Avg Vol (10d)289.71K
Technical Indicators
RSI (14)45.7
MACD0.0024
MACD Signal0.0017
MACD Hist.+0.0008
BB Upper0.1114 SEK
BB Middle0.0920 SEK
BB Lower0.0725 SEK
BB Width42.26%
ATR (14)0.0156 SEK
Vol Ratio (20d)9.06x